Source: Pharmacy Times articles
The findings suggest a potentially elevated risk of vision impairment with semaglutide (Ozempic, Wegovy; Novo Nordisk) use compared to other weight loss and diabetes medications.
Read More
by MM360 Staff | Apr 18, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
The findings suggest a potentially elevated risk of vision impairment with semaglutide (Ozempic, Wegovy; Novo Nordisk) use compared to other weight loss and diabetes medications.
Read More